The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues

Gene

Volumn 554, Issue 1, 2015, Pages 1-8

  Wang, Liguang ^a   Yu, Jianyu ^a,b   Xu, Jun ^a   Zheng, Chunlong ^a   Li, Xiaowei ^a   Du, Jiajun ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Department of General Surgery Chinese People's Liberation Army (PLA) 230th Hospital   (China)

Author keywords

Biomarker; Cancer; Meta analysis; MicroRNA 34

Indexed keywords

MICRORNA; MICRORNA 34; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN;

CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; COLORECTAL CANCER; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EMBASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOMA; HUMAN; LIVER CELL CARCINOMA; MEDLINE; META ANALYSIS; MULTIGENE FAMILY; NASOPHARYNX CARCINOMA; NEOPLASM; NON SMALL CELL LUNG CANCER; PERICARCINOUS TISSUE; PROSTATE CANCER; REVIEW; RNA ANALYSIS; STOMACH CANCER; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; WEB OF SCIENCE; COLORECTAL TUMOR; DNA MICROARRAY; FEMALE; LUNG TUMOR; MALE; METABOLISM; NASOPHARYNX TUMOR; PROGNOSIS; PROSTATE TUMOR; STOMACH TUMOR; UTERINE CERVIX TUMOR;

CARCINOMA, HEPATOCELLULAR; CARCINOMA, NON-SMALL-CELL LUNG; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84912122688     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.10.032     Document Type: Review

References (89)

1. Akao Y., Nakagawa Y., Hirata I., Iio A., Itoh T., Kojima K., Nakashima R., Kitade Y., Naoe T. Role of anti-oncomiRs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010, 17:398-408.
2. Ambs S., Prueitt R.L., Yi M., Hudson R.S., Howe T.M., Petrocca F., Wallace T.A., Liu C.G., Volinia S., Calin G.A., Yfantis H.G., Stephens R.M., Croce C.M. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008, 68:6162-6170.
3. An J., Choi K.P., Wells C.A., Chen Y.-P.P. Identifying co-regulating microRNA groups. J. Bioinforma. Comput. Biol. 2010, 08:99-115.
4. Bandi N., Vassella E. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol. Cancer 2011, 10:55.
5. Bandi N., Zbinden S., Gugger M., Arnold M., Kocher V., Hasan L., Kappeler A., Brunner T., Vassella E. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 2009, 69:5553-5559.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
8. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., Fearon E.R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007, 17:1298-1307.
9. Cai K.M., Bao X.L., Kong X.H., Jinag W., Mao M.R., Chu J.S., Huang Y.J., Zhao X.J. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int. J. Mol. Med. 2010, 25:565-571.
10. Chan S.K., Griffith O.L., Tai I.T., Jones S.J. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol. Biomarkers Prev. 2008, 17:543-552.
11. Chen H.C., Chen G.H., Chen Y.H., Liao W.L., Liu C.Y., Chang K.P., Chang Y.S., Chen S.J. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer 2009, 100:1002-1011.
12. Cheung T.H., Man K.N.M., Yu M.Y., Yim S.F., Siu N.S.S., Lo K.W.K., Doran G., Wong R.R.Y., Wang V.W., Smith D.I., Worley M.J., Berkowitz R.S., Chung T.K.H., Wong Y.F. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 2012, 11:2876-2884.
13. Chiu L.Y., Kishnani P.S., Chuang T.P., Tang C.Y., Liu C.Y., Bali D., Koeberl D., Austin S., Boyette K., Weinstein D.A., Murphy E., Yao A., Chen Y.T., Li L.H. Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. J. Gastroenterol. 2014, 49:1274-1284.
14. Corney D.C., Hwang C.I., Matoso A., Vogt M., Flesken-Nikitin A., Godwin A.K., Kamat A.A., Sood A.K., Ellenson L.H., Hermeking H., Nikitin A.Y. Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res. 2010, 16:1119-1128.
15. Dang Y., Luo D., Rong M., Chen G. Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PLoS One 2013, 8.
16. D'Angelo D., Palmieri D., Mussnich P., Roche M., Wierinckx A., Raverot G., Fedele M., Croce C.M., Trouillas J., Fusco A. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J. Clin. Endocrinol. Metab. 2012, 97:E1128-E1138.
17. Ding Y., Gu X.Y., Xu F., Shi X.Y., Yang D.Z., Zhong J., Wang S.M. MicroRNA expression profiling of mature ovarian teratomas. Oncol. Lett. 2012, 3:35-38.
18. Dutta K.K., Zhong Y., Liu Y.T., Yamada T., Akatsuka S., Hu Q., Yoshihara M., Ohara H., Takehashi M., Shinohara T., Masutani H., Onuki J., Toyokuni S. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci. 2007, 98:1845-1852.
19. Ferracin M., Veronese A., Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert. Rev. Mol. Diagn. 2010, 10:297-308.
20. Gallardo E., Navarro A., Vinolas N., Marrades R.M., Diaz T., Gel B., Quera A., Bandres E., Garcia-Foncillas J., Ramirez J., Monzo M. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 2009, 30:1903-1909.
21. Gao H., Zhao H., Xiang W. Expression level of human miR-34a correlates with glioma grade and prognosis. J. Neuro-Oncol. 2013, 113:221-228.
22. Garofalo M., Jeon Y.J., Nuovo G.J., Middleton J., Secchiero P., Joshi P., Alder H., Nazaryan N., Di Leva G., Romano G., Crawford M., Nana-Sinkam P., Croce C.M. miR-34a/c-Dependent PDGFR-(alpha)/(beta) downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS One 2013, 8.
23. Griffith O.L., Melck A., Jones S.J., Wiseman S.M. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J. Clin. Oncol. 2006, 24:5043-5051.
24. Guan P., Yin Z., Li X., Wu W., Zhou B. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J. Exp. Clin. Cancer Res. 2012, 31:54.
25. Hagman Z., Larne O., Edsjo A., Bjartell A., Ehrnstrom R.A., Ulmert D., Lilja H., Ceder Y. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int. J. Cancer 2010, 127:2768-2776.
26. Harata K., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Ogawa R., Katada T., Tanaka T., Shiozaki M., Fujii Y. MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma. Oncology Letters 2010, 1:685-689.
27. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
28. He L., He X., Lowe S.W., Hannon G.J. MicroRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat. Rev. Cancer 2007, 7:819-822.
29. He C., Xiong J., Xu X., Lu W., Liu L., Xiao D., Wang D. Functional elucidation of miR-34 in osteosarcoma cells and primary tumor samples. Biochem. Biophys. Res. Commun. 2009, 388:35-40.
30. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010, 17:193-199.
31. Hiroki E., Suzuki F., Akahira J.I., Nagase S., Ito K., Sugawara J.I., Miki Y., Suzuki T., Sasano H., Yaegashi N. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. Int. J. Cancer 2012, 131:E395-E404.
32. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., Zhang Y. miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006, 1:e116.
33. Huang Y., Liao D., Pan L., Ye R., Li X., Wang S., Ye C., Chen L. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation. Eur. J. Endocrinol. 2013, 168:675-681.
34. Jamieson N.B., Morran D.C., Morton J.P., Ali A., Dickson E.J., Carter C.R., Sansom O.J., Evans T.R.J., McKay C.J., Oien K.A. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin. Cancer Res. 2012, 18:534-545.
35. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
36. Katada T., Ishiguro H., Kuwabara Y., Kimura M., Mitui A., Mori Y., Ogawa R., Harata K., Fujii Y. MicroRNA expression profile in undifferentiated gastric cancer. Int. J. Oncol. 2009, 34:537-542.
37. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
38. Kumar B., Yadav A., Lang J., Teknos T.N., Kumar P. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One 2012, 7.
39. Lee J.W., Choi C.H., Choi J.J., Park Y.A., Kim S.J., Hwang S.Y., Kim W.Y., Kim T.J., Lee J.H., Kim B.G., Bae D.S. Altered microRNA expression in cervical carcinomas. Clin. Cancer Res. 2008, 14:2535-2542.
40. Lee C.H., Subramanian S., Beck A.H., Espinosa I., Senz J., Zhu S.X., Huntsman D., van de Rijn M., Gilks C.B. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One 2009, 4.
41. Li N., Fu H., Tie Y., Hu Z., Kong W., Wu Y., Zheng X. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009, 275:44-53.
42. Li Y., Guessous F., Zhang Y., Dipierro C., Kefas B., Johnson E., Marcinkiewicz L., Jiang J., Yang Y., Schmittgen T.D., Lopes B., Schiff D., Purow B., Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69:7569-7576.
43. Li T., Chen J.X., Fu X.P., Yang S., Zhang Z., Chen K.H., Li Y. MicroRNA expression profiling of nasopharyngeal carcinoma. Oncol. Rep. 2011, 25:1353-1363.
44. Li L., Xie X., Luo J., Liu M., Xi S., Guo J., Kong Y., Wu M., Gao J., Xie Z., Tang J., Wang X., Wei W., Yang M., Hung M.C., Xia X. Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion. Mol. Ther. 2012, 20:2326-2334.
45. Liu C.G., Calin G.A., Meloon B., Gamliel N., Sevignani C., Ferracin M., Dumitru C.D., Shimizu M., Zupo S., Dono M., Alder H., Bullrich F., Negrini M., Croce C.M. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9740-9744.
46. Liu M., Wu H., Liu T., Li Y., Wang F., Wan H., Li X., Tang H. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 2009, 19:828-837.
47. Liu H.Q., Brannon A.R., Reddy A.R., Alexe G., Seiler M.W., Arreola A., Oza J.H., Yao M., Juan D., Liou L.S., Ganesan S., Levine A.J., Rathmell W.K., Bhanot G.V. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst. Biol. 2010, 4.
48. Lodygin D., Tarasov V., Epanchintsev A., Berking C., Knyazeva T., Korner H., Knyazev P., Diebold J., Hermeking H. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
49. Luo Z.H., Zhang L.Y., Li Z., Li X.Y., Li G., Yu H.B., Jiang C., Dai Y.F., Guo X.F., Xiang J.J., Li G.Y. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med. Genet. 2012, 5.
50. Ma Y., Zhang P., Yang J., Liu Z., Yang Z., Qin H. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int. J. Cancer 2012, 130:2077-2087.
51. Ma Y., Bao-Han W., Lv X., Su Y., Zhao X., Yin Y., Zhang X., Zhou Z., MacNaughton W.K., Wang H. MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation. PLoS One 2013, 8.
52. Martens-Uzunova E.S., Jalava S.E., Dits N.F., van Leenders G.J., Moller S., Trapman J., Bangma C.H., Litman T., Visakorpi T., Jenster G. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 2012, 31:978-991.
53. Marzi M.J., Puggioni E.M., Dall'Olio V., Bucci G., Bernard L., Bianchi F., Crescenzi M., Di Fiore P.P., Nicassio F. Differentiation-associated microRNAs antagonize the Rb-E2F pathway to restrict proliferation. J. Cell Biol. 2012, 199:77-95.
54. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
55. Migliore C., Petrelli A., Ghiso E., Corso S., Capparuccia L., Eramo A., Comoglio P.M., Giordano S. MicroRNAs impair MET-mediated invasive growth. Cancer Res. 2008, 68:10128-10136.
56. Mudduluru G., Ceppi P., Kumarswamy R., Scagliotti G.V., Papotti M., Allgayer H. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene 2011, 30:2888-2899.
57. Osawa S., Shimada Y., Sekine S., Okumura T., Nagata T., Fukuoka J., Tsukada K. MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncology Letters 2011, 2:613-619.
58. Pineau P., Volinia S., McJunkin K., Marchio A., Battiston C., Terris B., Mazzaferro V., Lowe S.W., Croce C.M., Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:264-269.
59. Prattala R.S., Groth M.V., Oltersdorf U.S., Roos G.M., Sekula W., Tuomainen H.M. Use of butter and cheese in 10 European countries - a case of contrasting educational differences. Eur. J. Public Health 2003, 13:124-132.
60. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 2007, 26:731-743.
61. Roy S., Levi E., Majumdar A.P., Sarkar F.H. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J. Hematol. Oncol. 2012, 5.
62. Rozan L.M., El-Deiry W.S. p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ. 2007, 14:3-9.
63. Satzger I., Mattern A., Kuettler U., Weinspach D., Voelker B., Kapp A., Gutzmer R. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer 2010, 126:2553-2562.
64. Scapoli L., Palmieri A., Lo Muzio L., Pezzetti F., Rubini C., Girardi A., Farinella F., Mazzotta M., Carinci F. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int. J. Immunopathol. Pharmacol. 2010, 23:1229-1234.
65. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., Yuen S.T., Chan T.L., Kwong D.L., Au G.K., Liu C.G., Calin G.A., Croce C.M., Harris C.C. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.
66. Shen Z., Zhan G., Ye D., Ren Y., Cheng L., Wu Z., Guo J. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med. Oncol. 2012, 29:2473-2480.
67. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002, 2:103-112.
68. Stanitz E., Juhasz K., Toth C., Gombos K., Natali P.G., Ember I. Evaluation of microRNA expression pattern of gastric adenocarcinoma associated with socioeconomic, environmental and lifestyle factors in northwestern Hungary. Anticancer Res. 2013, 33:3195-3200.
69. Su Y., Ni Z., Wang G., Cui J., Wei C., Wang J., Yang Q., Xu Y., Li F. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int. Immunopharmacol. 2012, 13:468-475.
70. Tarasov V., Jung P., Verdoodt B., Lod\ygin D., Epanchintsev A., Menssen A., Meister G., Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6:1586-1593.
71. Tazawa H., Tsuchiya N., Izumiya M., Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:15472-15477.
72. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., Tokino T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008, 68:4123-4132.
73. Tsai K.W., Wu C.W., Hu L.Y., Li S.C., Liao Y.L., Lai C.H., Kao H.W., Fang W.L., Huang K.H., Chan W.C., Lin W.C. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int. J. Cancer 2011, 129:2600-2610.
74. Tsuchiyama K., Ito H., Taga M., Naganuma S., Oshinoya Y., Nagano K.I., Yokoyama O., Itoh H. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate 2013, 73:827-834.
75. Visani M., de Biase D., Marucci G., Cerasoli S., Nigrisoli E., Bacchi Reggiani M.L., Albani F., Baruzzi A., Pession A., P.s.g Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol Oncol. 2014, 8:417-430.
76. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2257-2261.
77. Walter B.A., Valera V.A., Pinto P.A., Merino M.J. Comprehensive microRNA profiling of prostate cancer. J. Cancer 2013, 4:350-357.
78. Wang M.J., Zhang P., Li Y., Liu G.H., Zhou B., Zhan L., Zhou Z.G., Sun X.F. The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer. Med. Oncol. 2012, 29:3113-3118.
79. Wang L.G., Ni Y., Su B.H., Mu X.R., Shen H.C., Du J.J. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int. J. Oncol. 2013, 42:957-962.
80. Wilting S.M., Snijders P.J.F., Verlaat W., Jaspers A., Van De Wiel M.A., Van Wieringen W.N., Meijer G.A., Kenter G.G., Yi Y., Le Sage C., Agami R., Meijer C.J.L.M., Steenbergen R.D.M. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2013, 32:106-116.
81. Wu J., Wu G., Lv L., Ren Y., Zhang X., Xue Y., Li G., Lu X., Sun Z., Tang K. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012, 33:519-528.
82. Wu X., Zhong D., Gao Q., Zhai W., Ding Z., Wu J. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether a go-go 1 expression. Int. J. Med. Sci. 2013, 10:676-682.
83. Wu Z., Wu Y., Tian Y., Sun X., Liu J., Ren H., Liang C., Song L., Hu H., Wang L., Jiao B. Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells. Oncology Letters 2013, 6:1447-1452.
84. Yang C., Wei W. The miRNA expression profile of the uveal melanoma. Sci. China Life Sci. 2011, 54:351-358.
85. Yao Y., Suo A.L., Li Z.F., Liu L.Y., Tian T., Ni L., Zhang W.G., Nan K.J., Song T.S., Huang C. MicroRNA profiling of human gastric cancer. Mol. Med. Rep. 2009, 2:963-970.
86. Yu J., Li A., Hong S.M., Hruban R.H., Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin. Cancer Res. 2012, 18:981-992.
87. Zhang J., Liu Y., Liu Z., Wang X.M., Yin D.T., Zheng L.L., Zhang D.Y., Lu X.B. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Int. J. Med. Sci. 2013, 10:585-592.
88. Zhang Q.H., Sun H.M., Zheng R.Z., Li Y.C., Zhang Q., Cheng P., Tang Z.H., Huang F. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene 2013, 527:26-32.
89. Zhang D., Zhou J., Dong M. Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF. Dig. Dis. Sci. 2014, 59:958-967.